Search

Author/Creator Tamada, Satoshi

2. Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients. (12th August 2020)

Authors:
Tomita, Yoshihiko; Tatsugami, Katsunori; Nakaigawa, Noboru; Osawa, Takahiro; Oya, Mototsugu; Kanayama, Hiroomi; Nakayama Kondoh, Chihiro; Sassa, Naoto; Nishimura, Kazuo; Nozawa, Masahiro; Masumori, Naoya; Miyoshi, Yasuhide; Kuroda, Shingo; Tanaka, Shingo; Kimura, Akiko; Tamada, Satoshi
Journal:
International journal of urology
Issue:
Volume 27:Number 11(2020)
Page Start:
952
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Comparative effectiveness of radical prostatectomy and curative radiotherapy in localized prostate cancer: long-term follow-up. (24th December 2016)

Authors:
Tamada, Satoshi; Ninomiya, Noriko; Kitamoto, Koichiro; Kato, Minoru; Yamasaki, Takeshi; Iguchi, Taro; Ohmachi, Tetsuji; Nakatani, Tatsuya
Journal:
Journal of radiation research
Issue:
Volume 58:Number 4(2017:Jul.)
Page Start:
552
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; van der Heijden, Michiel S; Castellano, Daniel; Galsky, Matthew D; Loriot, Yohann; Petrylak, Daniel P; Ogawa, Osamu; Park, Se Hoon; Lee, Jae-Lyun; De Giorgi, Ugo; Bögemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J; Gurney, Howard; Mukherjee, Som D; Fradet, Yves; Skoneczna, Iw...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy of naftopidil for nocturia in male patients with lower urinary tract symptoms: Comparison of morning and evening dosing. (25th November 2014)

Authors:
Tanaka, Tomoaki; Kuratsukuri, Katsuyuki; Yoshimura, Rikio; Adachi, Takahisa; Yamaguchi, Tetsuo; Ohmachi, Tetsuji; Yamamoto, Shinji; Nakamura, Takahiro; Tamada, Satoshi; Nakatani, Tatsuya
Journal:
International journal of urology
Issue:
Volume 22:Number 3(2015)
Page Start:
317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides. (February 2014)

Authors:
Kawashima, Hidenori; Obayashi, Aiko; Kawamura, Marie; Masaki, Sakae; Tamada, Satoshi; Iguchi, Taro; Uchida, Junji; Kuratsukuri, Katsuyuki; Tanaka, Tomoaki; Nakatani, Tatsuya
Journal:
BJU international
Issue:
Volume 113(2014)Supplement 2
Page Start:
320
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides. (February 2014)

Authors:
Kawashima, Hidenori; Obayashi, Aiko; Kawamura, Marie; Masaki, Sakae; Tamada, Satoshi; Iguchi, Taro; Uchida, Junji; Kuratsukuri, Katsuyuki; Tanaka, Tomoaki; Nakatani, Tatsuya
Journal:
BJU international
Issue:
Volume 113:Number 2(2014:Feb.)
Page Start:
320
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗